References

1. Biomarkers for amyotrophic lateral sclerosis. Expert Rev Mol Diagn [Internet] (3):387–398. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi? md=Retrieve&db=PubMed&dopt=Citation&list
_uids=167 06741 PMID: 16706741 Bowser R, Cudkowicz M, Kaddurah-Daouk R. (2006)

2. Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation. Nat Rev Drug Discov. 22(3):185-212. doi: 10.1038/s41573-022-00612-2. Epub 2022 Dec 21. PMID: 36543887; PMCID: PMC9768794 Mead RJ, Shan N, Reiser HJ, Marshall F, Shaw PJ. (2023)

3. Reducing sample size requirements for future ALS clinical trials with a dedicated electrical impedance myography system. Amyotroph Lateral Scler Frontotemporal Degener. 19(7-8):555-561. doi: 10.1080/21678421.2018.1510008. Epub 2018 Sep 28. PMID: 30265154; PMCID:
PMC6438779. Shefner JM, Rutkove SB, Caress JB, Benatar M, David WS, Cartwright MS, Macklin EA, Bohorquez JL. (2018)

4. Rutkove SB, Kapur K, Zaidman CM, Wu JS, Pasternak A, Madabusi L, Yim S, Pacheck A, Szelag H, Harrington T, Darras BT. Electrical impedance myography for assessment of Duchenne muscular dystrophy. Ann Neurol. 2017 May;81(5):622-632. doi: 10.1002/ana.24874. Epub 2017 May 4. PMID: 28076894; PMCID: PMC5444980.

5. Improved ALS clinical trials through frequent at-home self-assessment: a proof of concept study. Ann Clin Transl Neurol. (7):1148–1157. PMID: 32515889 Rutkove SB, Narayanaswami P, Berisha V, Liss J, Hahn S, Shelton K, Qi K, Pandeya S, Shefner JM. (2020)

6. Potential Utility of Electrical Impedance Myography in Evaluating Age-Related Skeletal Muscle Function Deficits. Front Physiol. 7;12:666964. doi: 10.3389/fphys.2021.666964. PMID:34025454; PMCID: PMC8138591. Clark BC, Rutkove S, Lupton EC, Padilla CJ, Arnold WD (2021)

7. Esper GJ, Shiffman CA, Aaron R, Lee KS, Rutkove SB. Assessing neuromuscular disease with multifrequency electrical impedance myography. Muscle Nerve. 2006 Nov;34(5):595-602. doi: 10.1002/mus.20626. PMID: 16881067

8. Estimating Myofiber Size With Electrical Impedance Myography: a Study In Amyotrophic Lateral Sclerosis MICE. Muscle Nerve;58(5):713-717. doi: 10.1002/mus.26187. Epub. 2. PMID:30175407; PMCID: PMC6246784. Kapur K, Nagy JA, Taylor RS, Sanchez B, Rutkove SB. (2018)

9. Test-retest reproducibility of 50 kHz linear-electrical impedance myography. Clin Neurophysiol. 2006 Jun;117(6):1244-8. doi:10.1016/j.clinph.2005.12.029. Epub PMID: 16644269. Rutkove SB, Lee KS, Shiffman CA, Aaron R.(2006)

10. Diminished muscle integrity in patients with fibrodysplasia ossificans progressiva assessed with at-home electrical impedance myography. Sci Rep. 12, 20908 https://doi.org/10.1038/s41598-022-25610-7 Farid, A., Golden, E., Robicheau, S. et al. (2022)

11. Electrophysiologic biomarkers for assessing disease progression and the effect of riluzole in SOD1 G93A ALS mice. PLoS One. 8(6):e65976. doi: 10.1371/journal.pone.0065976. PMID: 23762454; PMCID: PMC3675066. Li J, Sung M, Rutkove SB. (2013)

12. Improved ALS clinical trials through frequent at-home self-assessment: a proof of concept study. Ann Clin Transl Neurol. 7(7):1148-1157. doi: 10.1002/acn3.51096. Epub 2020 Jun 9. Erratum in: Ann Clin Transl Neurol. 2021 Aug;8(8):1770. PMID: 32515889; PMCID: PMC7359124. Rutkove SB, Narayanaswami P, Berisha V, Liss J, Hahn S, Shelton K, Qi K, Pandeya S, Shefner JM (2020)

13. ALS longitudinal studies with frequent data collection at home: study design and baseline data. Amyotroph Lateral Scler Frontotemporal Degener. 20(1-2):61-67. doi: 10.1080/21678421.2018.1541095. Epub 2018 Nov 28. PMID: 30486680; PMCID: PMC6513689. Rutkove SB, Qi K, Shelton K, Liss J, Berisha V, Shefner JM. (2019)

14. Electrical impedance myography as a biomarker to assess ALS progression. Amyotroph Lateral Scler [Internet]. 13(5):439–445. Rutkove SB, Caress JB, Cartwright MS, Burns TM, Warder J, David WS, Goyal N, Maragakis NJ, Clawson L, Benatar M, Usher S, Sharma KR, Gautam S, Narayanaswami P, Raynor EM, Watson M Lou, Shefner JM. (2012)